The South & Central America anti-infective agents market is projected to grow from US$ 5,713.39 million in 2022 to US$ 6,498.70 million by 2028, at a CAGR of 2.2% during the forecast period.
In South & Central America, the market exhibits growth opportunities with progressive developments in Brazil, such as growing medical tourism and an increasing number of government initiatives to create awareness about anti-infective agents. The growing prevalence of infectious diseases is a major concern among the Brazilian population, thereby increasing the demand for anti-infective agents. These factors stimulate the growth of the anti-infective agent market in this region.
A few major countries contributing to the growth of the anti-infective agents market include Chile, Colombia, Peru, and Bolivia. The aging population, high prevalence of osteoporosis, and growing number of orthopedic surgeries are prime factors for the market growth. The presence of international healthcare technology players further strengthens the market's growth in the region. For instance, Surbiton reaffirms its position as Argentina's flagship Company in the field of medical devices of international quality. Moreover, the company has an active presence in several countries, including Peru, Colombia, and Argentina. Such developments are estimated to contribute to the growth of the Rest of the South & Central America anti-infective agents anti-infective agents market during the forecast period.
Vendors can attract new customers and expand their footprints in emerging markets with new features and technologies. This factor is likely to drive the South & Central America anti-infective agents market at a good CAGR during the forecast period.
South & Central America Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Anti-Infective Agents Market Segmentation
The South & Central America anti-infective agents market is segmented based on type, range, route of administration, indication, distribution channel, and country. Based on type, the market is segmented into anti-bacterial, anti-viral, anti-fungal, and others. The anti-viral segment is expected to account for the largest market share by the end of 2022.
Based on range, the market is segmented into broad spectrum and narrow spectrum. By the end of 2022, the narrow spectrum segment will likely hold a larger market share.
Based on route of administration, the market is segmented into topical, oral, IV, and others. By the end of 2022, the IV segment is likely to hold the largest market share.
Based on indication, the market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. In 2022, the others segment is projected to hold the largest share of the market.
Based on distribution channel, the market is segmented into hospital pharmacies, specialty pharmacies, e-commerce, and others. By the end of 2022, the hospital pharmacies segment is likely to hold the largest market share.
Based on country, the market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil is expected to hold the largest market share by the end of 2022.
Abbott; Allergan Plc.; Astellas Pharma Inc.; Bayer AG; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline plc.; Merck & Co., Inc.; and Novartis AG are the leading companies in the South & Central America anti-infective agents market.
At 2.5% CAGR, the South & Central America Anti-Infective Agents Market is speculated to be worth US$ 6,498.70 Million by 2028, says The Insight Partners
According to The Insight Partners’ research, the South & Central America anti-infective agents market was valued at US$ 5,713.39 million in 2022 and is expected to reach US$ 6,498.70 million by 2028, registering an annual growth rate of 2.5% from 2022 to 2028. Develoment of new anti-infective agents and surging investments in R&D activities in pharmaceutical sector are the critical factors attributed to the market expansion.
Developments in the medical devices industry have motivated the existing players and new entrants to introduce their novel products in the market. Additionally, there have been lots of developments in techniques involved in medical examinations. The use of illuminating light sources with longer shelf life in gynecological procedures is encouraging market players to develop and introduce anti-infective agents. TLRs, or toll-like receptors, are important components of innate immunity. They have the ability to detect a variety of microbes, including viruses, bacteria, fungus, and protozoa. Innate immunological reactions can directly influence adaptive immune reactions. Therefore, TLRs are considered therapeutic targets for autoimmune diseases, including autoimmune disorders, allergies, sepsis, and cancer. Two COVID-19 vaccines were created using mRNA technology (Pfizer-BioNTech35 and Moderna36), demonstrating safety and high efficacy. These vaccines currently have conditional marketing authorization from the European Medicines Agency (EMA) and emergency use authorization (EUA) from the US Food and Drug Administration (FDA). Such developments are expected to present lucrative opportunities for the growth of the anti-infective agent market in the years to come.
On the contrary, emergence of anti-infective drugs resistance and their various side effects hurdles the growth of South & Central America anti-infective agents market.
Based on type, the market is segmented into anti-bacterial, anti-viral, anti-fungal, and others. The anti-viral segment held the largest market share of 48.1% in 2022 with a revenue of US$ 2,748.92 million. Further, it is going to reach US$ 3,081.96 million by 2028 at decent CAGR of 1.9% during the forecasted period.
Based on range, the anti-infective agents market sphere is bifurcated into broad spectrum and narrow spectrum. The former held 67.7% market share in 2022, amassing US$ 3,868.81 million. It is projected to garner US$ 4,360.67 million by 2028 to expand at 2.0% CAGR during 2022–2028.
Based on route of administration, the market is segmented into topical, oral, IV, and others. With 49.8% share IV segment dominated the market in 2022. It accrued US$ 2,845.47 million in 2022 and is estimated to reach by US$ 3,203.08 million by 2028 at a CAGR of 2.0% during 2022-2028.
Based on indication, the market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. The others segment held the largest market share of 38.8% in 2022 with a revenue of US$ 2,219.09 million. Further, it is going to reach US$ 2,430.63 million by 2028 at decent CAGR of 1.5% during the forecasted period.
Based on distribution channel, the market is segmented into hospital pharmacies, specialty pharmacies, e-commerce, and others. With 44.9% share of the domain, the hospital pharmacies segment dominated the market in 2022. It accrued US$ 2,563.03 million in 2022 and is estimated to generate US$ 2,908.30 million by 2028 to grow at a CAGR of 2.1% over the forecast period.
Our country analysis states that Brazil captured 45.6% market share in 2022. It was assessed at US$ 2,603.02 million in 2022 and is likely to hit US$ 2,991.91 million by 2028, exhibiting a CAGR of 2.3% during the forecast period.
Key players dominating the South & Central America anti-infective agents market are Abbott; Allergan Plc.; Astellas Pharma Inc.; Bayer AG; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline plc.; Merck & Co., Inc.; and Novartis AG are among others.
Few of the recent key developments among the top market players are listed below:
In April 2021, Abbott launched adult vaccination program for flu, typhoid, and more vaccines to safeguard people's health. The program aimed to create awareness regarding immunization in adult populations. In January 2021, Merck confirmed an agreement with UNICEF to establish the world’s first global Ebola vaccine stockpile with ERVEBO® (Ebola Zaire Vaccine, Live). ERVEBO is a vaccine indicated for the prevention of disease caused by Zaire ebolavirus in individuals 18 years of age and older.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Anti-Infective Agents Market – By Type
1.3.2 SAM Anti-Infective Agents Market – By Range
1.3.3 SAM Anti-Infective Agents Market – By Route of Administration
1.3.4 SAM Anti-Infective Agents Market – By Indication
1.3.5 SAM Anti-Infective Agents Market – By Distribution Channel
1.3.6 SAM Anti-Infective Agents Market – By Country
2. SAM Anti-Infective Agents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Anti-infective agents Market – Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM Anti-Infectives Agents Market – Key Market Dynamics
5.1 Key Drivers
5.1.1 Chronic Diseases Rising
5.1.2 Rising Government Support for Research Activities and Clinical Trials
5.2 Market Restraints
5.2.1 Emergence of Anti-infective Drugs Resistance and Their Side Effects
5.3 Market Opportunities
5.3.1 Development of Advanced Anti-infective Agents
5.4 Future Trends
5.4.1 R&D Activities in Pharmaceutical Sector Witnessing High Investments
5.5 Impact Analysis
6. Anti-Infectives Agents Market – SAM Analysis
6.1 SAM Anti-Infectives Agents Market Revenue Forecast and Analysis
7. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 – Type Overview
7.1 SAM Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
7.2 Anti-Viral
7.2.1 Overview
7.2.2 Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
7.3 Anti-Bacterial
7.3.1 Overview
7.3.2 Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
7.4 Anti-Fungal
7.4.1 Overview
7.4.2 Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 – Range
8.1 Overview
8.2 SAM Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
8.3 Narrow Spectrum
8.3.1 Overview
8.3.2 Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
8.4 Broad Spectrum
8.4.1 Overview
8.4.2 Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)
9. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 – Route of Administration
9.1 Overview
9.2 SAM Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
9.3 IV
9.3.1 Overview
9.3.2 IV Market Revenue and Forecast to 2028 (US$ Million)
9.4 Oral
9.4.1 Overview
9.4.2 Oral Market Revenue and Forecast to 2028 (US$ Million)
9.5 Topical
9.5.1 Overview
9.5.2 Topical Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 – Indication
10.1 Overview
10.2 SAM Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
10.3 HIV
10.3.1 Overview
10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)
10.4 Tuberculosis
10.4.1 Overview
10.4.2 Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
10.5 Respiratory Infection
10.5.1 Overview
10.5.2 Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
10.6 Pneumonia
10.6.1 Overview
10.6.2 Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
11. SAM Anti-Infectives Agents Market Analysis and Forecast to 2028 – Distribution Channel
11.1 Overview
11.2 SAM Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
11.3 Hospital Pharmacies
11.3.1 Overview
11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.4 Retail Pharmacies
11.4.1 Overview
11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.5 Specialty Pharmacies
11.5.1 Overview
11.5.2 Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.6 E-Commerce
11.6.1 Overview
11.6.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
11.7 Others
11.7.1 Overview
11.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
12. SAM Anti-Infectives Agents Market Analysis and Forecasts To 2028 – Country Analysis
12.1 Overview
12.1.2 SAM Anti-Infective Agents Market Revenue and Forecast to 2028, by Country (%)
12.1.2.1 Brazil: Anti-Infective Agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.1 Overview
12.1.2.1.2 Brazil Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.3 Brazil: Anti-Infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.1.2.1.4 Brazil: Anti-Infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.1.2.1.5 Brazil: Anti-Infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.2.1.6 Brazil: Anti-Infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.1.2.1.7 Brazil: Anti-Infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.1.2.2 Argentina: Anti-Infective Agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.1 Overview
12.1.2.2.2 Argentina Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.2.3 Argentina: Anti-infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.1.2.2.4 Argentina: Anti-infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.1.2.2.5 Argentina: Anti-infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.2.2.6 Argentina: Anti-infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.1.2.2.7 Argentina: Anti-infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
12.1.2.3 Rest of the SAM: Anti-Infective Agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.1 Overview
12.1.2.3.2 Rest of the SAM Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
12.1.2.3.3 Rest of the SAM: Anti-Infectives Agents Market, by Type, 2019–2028 (US$ Million)
12.1.2.3.4 Rest of the SAM: Anti-Infectives Agents Market, by Range, 2019–2028 (US$ Million)
12.1.2.3.5 Rest of the SAM: Anti-Infectives Agents Market, by Route of Administration, 2019–2028 (US$ Million)
12.1.2.3.6 Rest of the SAM: Anti-Infectives Agents Market, by Indication, 2019–2028 (US$ Million)
12.1.2.3.7 Rest of the SAM: Anti-Infectives Agents Market, by Distribution Channel, 2019–2028 (US$ Million)
13. Anti-infectives Agents Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies In The Anti-infective agents Market, 2018-2022
13.3 Organic Developments
13.3.1 Overview
13.3.2 Organic Growth Strategies In The Anti-infective agents Market, 2018-2022
13.4 Inorganic Developments
13.4.1 Overview
13.4.2 Inorganic Growth Strategies In The Anti-infective agents Market, 2018-2022
14. Anti-Infectives Agents Market- Company Profiles
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Allergan Plc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Astellas Pharma Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck & Co., Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bayer AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Boehringer Ingelheim International GmbH
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 F. HOFFMANN-LA ROCHE LTD.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Gilead Sciences, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 GlaxoSmithKline plc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Novartis AG
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES.
Table 1. Brazil Anti-Infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil Anti-Infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 3. Brazil Anti-Infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil Anti-Infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil Anti-Infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina Anti-infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. Argentina Anti-infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 8. Argentina Anti-infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina Anti-infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 10. Argentina Anti-infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 11. Rest of the SAM Anti-Infectives Agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of the SAM Anti-Infectives Agents Market, by Range – Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of the SAM Anti-Infectives Agents Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of the SAM Anti-Infectives Agents Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of the SAM Anti-Infectives Agents Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 16. Recent Inorganic Growth Strategies In The Anti-infective agents Market
Table 17. Glossary of Terms, SAM Anti-infectives Agents Market
LIST OF FIGURES.
Figure 1. SAM Anti-Infective Agents Market Segmentation
Figure 2. SAM Anti-Infective Agents Market Segmentation, by Country
Figure 3. SAM Anti-infective agents Market Overview
Figure 4. Anti-Viral Segment Held Largest Share of Product Segment in SAM Anti-Infective Agents Market
Figure 5. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. SAM: PEST Analysis
Figure 7. Experts Opinion
Figure 8. SAM Anti-Infectives Agents Market Impact Analysis of Drivers and Restraints
Figure 9. SAM Anti-infectives agents Market– Revenue Forecast and Analysis – 2019 - 2028
Figure 10. SAM Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
Figure 11. SAM Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. SAM Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. SAM Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. SAM Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. SAM Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
Figure 16. SAM Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. SAM Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. SAM Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
Figure 19. SAM IV Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. SAM Oral Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. SAM Topical Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. SAM Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. SAM Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
Figure 24. SAM HIV Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. SAM Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. SAM Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. SAM Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. SAM Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. SAM Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
Figure 30. SAM Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. SAM Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. SAM Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. SAM E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. SAM Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. SAM Anti-Infective Agents Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 36. SAM Anti-Infective Agents Market Revenue and Forecast to 2028, by Country (%)
Figure 37. Brazil: Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Argentina: Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. Rest of the SAM: Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
Figure 40. Growth Strategies In The Anti-infective agents Market, 2018-2022
Figure 41. Recent Organic Growth Strategies In The Anti-infective agents Market
